# Sources — Duke Kahanamoku

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

Accessed November 6, 2026. The canonical source metadata and claim links are in `case.json`.

## Historical evidence

1. PBS (WNET), *American Masters*. “Duke Kahanamoku: biography and life timeline.” Supports that he “was born in Honolulu, Hawai'i on August 24, 1890”; the Olympic gold medals of 1912 and 1920 and the silver of 1924; that in 1914 he “introduces surfing to the U.S. Atlantic coast”; that from 1922 he “resides in Los Angeles and spends years pursuing an acting career”; that in 1934 he was “appointed Sheriff of Honolulu, Hawaii for the first time,” re-elected until the post was abolished in 1960; that in 1940 he “marries Nadine Alexander”; that in 1956 he was “the official U.S. representative at the Melbourne Olympics”; and that on January 22, 1968, he “dies of a heart attack at age 77.” https://www.pbs.org/wnet/americanmasters/duke-kahanamoku-biography-and-life-timeline/21754
2. Luis C. “A wonderful life” (timeline). *Honolulu Star-Advertiser*, January 22, 2018. Supports his birth “at Hale'akala, Honolulu home of Princess Bernice Pauahi Bishop”; the Hui Nalu Surf Club in 1911; the 1912, 1920 and 1924 medals; the Freshwater Beach exhibition of December 24, 1914; “1934-1960: Elected for 13 consecutive terms as sheriff of Honolulu”; his marriage “in Kailua-Kona” on August 2, 1940; “Ambassador of Aloha” from 1960; the swimming (1965) and surfing (1966) halls of fame; his death “after suffering heart attack at Waikiki Yacht Club”; and the beachboy funeral of January 27, 1968. https://staradvertiser.com/?p=715741
3. Luis C. “Legacy of Hawaii's most beloved, honored athlete endures 50 years after his death.” *Honolulu Star-Advertiser* (successor of the *Star-Bulletin* and the *Advertiser*), January 22, 2018. Supports that he “had previous medical incidents, including a heart attack in 1952 and a cerebral blood clot in 1962,” and that “he had no great personal wealth.” https://staradvertiser.com/?p=715743
4. Olympedia. “Duke Kahanamoku.” Supports his full name, “Duke Paoa Kahino Makoe Hulikohoa Kahanamoku”; birth on August 24, 1890 and death on January 22, 1968, in Honolulu; the medal record (three gold, two silver); that he “was named after the Duke of Edinburgh”; and “Sheriff of Honolulu from 1932-61.” https://www.olympedia.org/athletes/51429
5. EBSCO Research Starters. “Duke Kahanamoku.” Supports that he was named after his father; that he never smoked or drank; that he continued to swim and sail “even after he suffered several heart attacks and had survived a brain operation”; and that on January 22, 1968, he “collapsed at the Waikiki Yacht Club and was rushed to Kaiser Foundation Hospital, where he died.” https://ebsco.com/research-starters/history/duke-kahanamoku
6. International Swimming Hall of Fame. “August 24: celebrate the birth of one of Hawaii's greatest sons and 1965 ISHOF Honoree, Duke Kahanamoku.” Supports his 1965 induction as an “Honor Swimmer” and his Olympic record. https://ishof.org/?p=2428
7. *Encyclopedia of World Biography* (Gale, via Encyclopedia.com). “Kahanamoku, Duke.” Supports that “he never drank or smoked, rarely fought, and trained consistently,” and gives 1932 to 1961 for his years as sheriff. https://www.encyclopedia.com/doc/1G2-3404707611.html
8. HISTMED Master Roster v3. Internal project source; not treated as independent corroboration.

## Clinical guidance

1. Heidenreich PA, et al. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure. *Circulation* 2022;145(18):e895-e1032 (PMID 35363499): diagnosis with natriuretic peptides and echocardiography; ARNI, evidence-based beta-blocker, MRA and SGLT2 inhibitor for HFrEF; the 36-hour washout from an ACE inhibitor; diuretics for congestion; intravenous iron for iron deficiency; coronary angiography in suspected ischemic cardiomyopathy; primary-prevention ICD after at least three months of GDMT when the ejection fraction stays at 35% or below; exercise training and cardiac rehabilitation; avoiding excess sodium; vaccination. https://pubmed.ncbi.nlm.nih.gov/35363499/
2. Maddox TM, et al. 2024 ACC Expert Consensus Decision Pathway for Treatment of Heart Failure With Reduced Ejection Fraction. *J Am Coll Cardiol* 2024;83(15):1444-1488 (PMID 38466244): starting all four classes within weeks, titration steps and laboratory monitoring, and sick-day rules. https://pubmed.ncbi.nlm.nih.gov/38466244/
3. Al-Khatib SM, et al. 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death. *Circulation* 2018;138(13):e272-e391 (PMID 29084731): primary-prevention ICD criteria. https://pubmed.ncbi.nlm.nih.gov/29084731/
4. Virani SS, et al. 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease. *Circulation* 2023;148(9):e9-e119 (PMID 37471501): high-intensity statin and LDL goals. https://pubmed.ncbi.nlm.nih.gov/37471501/
5. CMID: Clinical Monitoring Intelligence Database (Aether Forge, 2026), heart failure monograph (blood pressure, heart rate, weight, volume status and NYHA class at every visit; metabolic panel with magnesium one to two weeks after starting or changing a diuretic, ARNI, MRA or SGLT2 inhibitor, then every three to six months; initial workup including iron studies; intravenous iron when ferritin is below 100 ng/mL; echocardiogram at diagnosis and after three to six months of optimized therapy for device decisions; KCCQ every three to six months; cardiac rehabilitation under CMS NCD 20.10.1) and ischemic heart disease monograph (lipid panel after a statin change). https://patrickrutledge.github.io/topthirty/
6. Sentell T, et al. Potentially Preventable Hospitalizations for Congestive Heart Failure Among Asian Americans and Pacific Islanders in Hawaiʻi. *J Immigr Minor Health* 2015;17(5):1289-1297 (PMID 25204624): after adjustment, Native Hawaiians of every age and sex group had significantly higher rates of potentially preventable heart failure hospitalization than White residents, and about half of these hospitalizations were in people under 65. https://pubmed.ncbi.nlm.nih.gov/25204624/
7. Ke Ola Mamo, a Native Hawaiian Health Care System serving Oʻahu, which lists medical care, lomilomi and community health workers among its services. https://keolamamo.org/
8. Centers for Medicare & Medicaid Services, Medicare Wellness Visits; Medicare Preventive Services reference (Aether Forge, 2026); U.S. Preventive Services Task Force: colorectal cancer (2021), prostate cancer (2018), abdominal aortic aneurysm (2019), falls prevention (2024) and hepatitis C (2020); CDC Adult Immunization Schedule by Age. https://www.cms.gov/outreach-and-education/medicare-learning-network-mln/mlnproducts/preventive-services/medicare-wellness-visits.html; https://patrickrutledge.github.io/preventative_services/; https://www.uspreventiveservicestaskforce.org/uspstf/recommendation-topics/uspstf-a-and-b-recommendations; https://www.cdc.gov/vaccines/hcp/imz-schedules/adult-age.html

## Editorial resolutions

- **Sources.** The case relies on PBS *American Masters*, two *Honolulu Star-Advertiser* articles of 2018, Olympedia, EBSCO, the International Swimming Hall of Fame and the *Encyclopedia of World Biography*. The Hawaiʻi State Archives, the Bishop Museum, olympics.com (the athlete page timed out), the *New York Times* obituary and the 1968 *Star-Bulletin* and *Advertiser* obituaries were not read; David Davis's biography *Waterman* was not read and is not cited. A 1962 wire report on Papers Past of an operation “for a blood clot on the brain at Kaiser Hospital,” seen in a search result, could not be fetched and is not cited. Wikipedia and popular sites were not used.
- **Recent-death rule.** He died in 1968, so the rule does not apply. A sick visit is included.
- **Heart attack date (correction to the brief).** The brief cited a heart attack in 1955. No source read gives 1955; the *Star-Advertiser* gives 1952, and EBSCO says he had several heart attacks without dates. The record uses 1952 (CLM-0009, certainty “probable”).
- **Brain operation (correction to the brief).** The brief mentioned surgery for a brain blood clot or tumor in about 1962. The *Star-Advertiser* records a cerebral blood clot in 1962 and EBSCO a brain operation; no source read mentions a tumor. It is recorded as later history (CLM-0010) and not used in the modern episode.
- **Index age and dates.** The index visit on March 16, 2026 maps to March 16, 1957, when he was 66 and sheriff of Honolulu, five years after the 1952 heart attack and five years before the 1962 operation. The synthetic date of birth is 1959-08-24, a shift of 69 years. The visits on March 30, April 13, April 22, April 27, September 14 and September 28, 2026 map to the same days of 1957; he turns 67 before the last two. The medicines begun after the modern heart attack are dated June 21, 2021 (mapping to 1952; the month of the real heart attack is not known). His travel in 1957 is not documented in the sources read; nothing places a visit in conflict with a documented event. The presenting pattern is breathlessness, ankle swelling and tiredness years after a heart attack, resolved into HFrEF at the second visit.
- **Name and alias.** The display name splits simply into given and family names, so identity.name_parts is not used. The alias is Olympedia's full name, Duke Paoa Kahino Makoe Hulikohoa Kahanamoku, which appears in no other record; the brief's spelling (Kahinu Mokoe Hulikohola) and the shorter form Duke Paoa Kahanamoku were not found in a source that could be fetched. “Duke” alone is not an alias. The notes call him Mr. Kahanamoku, as the modern episode records that he asked.
- **Conflicts recorded.** His years as sheriff are 1934 to 1960 in PBS and the *Star-Advertiser* and 1932 to 1961 in Olympedia, the *Encyclopedia of World Biography* and EBSCO; either way he was sheriff in 1957. One International Swimming Hall of Fame tribute implies an August 14 birthday by its arithmetic; the dated sources give August 24.
- **Living people and relatives.** His wife appears only in a documented claim (CLM-0007) and is given no role, statement or health fact. His ʻohana in the modern episode, his health care agent and the friend he swims with are synthetic and unnamed. Princess Bernice Pauahi Bishop appears only in the birth claim. No relative or historical person is given a modern statement, decision or health fact.
- **Culturally safe care.** The record follows the approach of the dataset's earlier record of a Native Hawaiian patient: his ʻohana is involved as he chooses and he makes the decisions; lomilomi through Ke Ola Mamo, a real Native Hawaiian Health Care System that lists it among its services, is offered alongside clinic care; no practice or ceremony is described, and the clinic asks nothing further. He is asked to tell the clinic before using any plant medicine so interactions can be checked. His diet is described in his own words, without claiming anything about Native Hawaiian diets in general. The equity point cites the Hawaiʻi study of preventable heart failure hospitalizations; the record quotes no rate beyond that study's findings.
- **Diagnosis decisions.** HFrEF from ischemic cardiomyopathy (I50.22) is recorded at the second visit: NT-proBNP 2,450 pg/mL and an ejection fraction of 30% with a thinned, akinetic anterior wall and apex. The old myocardial infarction (I25.2) is linked to the 1952 heart attack (placement both_with_link); nothing in the record says he had heart failure in his lifetime. Iron deficiency without anemia (E61.1) was found at intake. The intake documents show only what was known at intake.
- **Treatment choices.** (1) Lisinopril stopped and sacubitril-valsartan started 36 hours later; the medication start is dated the consultation day, with the washout in its instructions. (2) Metoprolol tartrate replaced by carvedilol, an evidence-based beta-blocker. (3) Empagliflozin with sick-day rules. (4) Spironolactone 12.5 mg at the third visit, with potassium 4.5 mmol/L and eGFR 69. (5) Intravenous ferric carboxymaltose 750 mg twice for ferritin 62 ng/mL. (6) Coronary angiography showed a chronic total occlusion of the left anterior descending artery feeding a thinned scar, with mild disease elsewhere: no revascularization; no viability imaging was done, a judgment the owner may review. (7) Atorvastatin 80 mg; LDL 92 to 62 mg/dL. (8) Furosemide reduced from 40 to 20 mg once dry. (9) Sodium guidance without routine fluid restriction.
- **Defibrillator decision.** The ejection fraction rose from 30% to 38% after more than five months on all four classes, above the 35% threshold, so a primary-prevention ICD was not indicated; QRS 104 ms, so no CRT. The record notes that sacubitril-valsartan stayed at its starting dose for most of that time and says what would change the decision. His wish to discuss any device with his ʻohana is recorded in his advance care planning.
- **Ocean safety.** Cardiac rehabilitation for heart failure began six weeks after angiography and the last new medicine, as CMS NCD 20.10.1 requires, with supervised pool swimming, then calm water inside the reef with a companion and near a lifeguard, no breath-hold diving and no big surf until cleared. This adapts general exercise guidance to his life; no guideline gives ocean-specific rules.
- **Synthetic clinical picture.** Everything in the modern episode is synthetic: symptoms, the heart attack five years before intake, every blood pressure, all laboratory values, the ECGs, the chest X-ray, the echocardiograms, the angiogram, scores (PHQ-2, KCCQ-12, Mini-Cog, AUDIT-C), medicines and outcomes. Height (185 cm) and weights are synthetic. Reference ranges are typical adult male ranges; the ferritin range notes the heart failure threshold.
- **Sick visit.** Viral gastroenteritis (A08.4) with volume depletion, potassium 5.5 mmol/L and creatinine 1.52 mg/dL nine days after spironolactone, chosen because it follows from four medicines that act on the kidney and insinuates no undocumented diagnosis; the ECG showed no hyperkalemic changes, and sick-day holds brought potassium to 4.8 mmol/L five days later. It is not a historical claim.
- **Annual wellness visit.** A subsequent annual wellness visit at 67 (HCPCS G0439 and CPT 99497 in plain text); the record says his first was with his previous physician (synthetic). Judgment calls: high-dose influenza, RSV (heart failure, age 60 to 74) and COVID-19 that day, with zoster and Tdap at the next visit; FIT for colorectal screening; PSA declined after shared decision-making; no aneurysm screening as a never smoker; hepatitis C once; advance care planning with an unnamed member of his ʻohana as agent, recording that his own Hawaiian practices are to be respected without describing them.
- **Focused visits.** The four chronic-care follow-ups (two weeks with the consultation, two weeks after the first three GDMT medicines, two weeks after spironolactone and five days after the sick visit, and six months) are documented as focused visits on the CMID heart failure and ischemic heart disease monographs, the 2022 heart failure guideline and the 2024 HFrEF decision pathway. One deviation is recorded instead of an invented result: the sacubitril-valsartan increase planned two weeks after the fourth visit, and the metabolic panel due a week after it, never happened, because he put off the laboratory visit twice for work and the nurse's call was not repeated. No laboratory harm resulted (potassium 4.6 mmol/L and creatinine 1.14 mg/dL at six months), but the ARNI stayed at its starting dose for about five months, which may have limited his recovery. The corrective action was laboratory tests drawn at the clinic on the day of each change or by the nurse at home, with nurse calls continuing until each step is done. The one-to-two-week check after spironolactone was covered by the sick-visit panel at nine days and the fourth-visit panel at two weeks. Synthetic findings introduced: iron deficiency, the angiogram, the hyperkalemia during gastroenteritis, the KCCQ-12 rising from 38 to 80, and the ejection fraction rising to 38%.
- **Consultation.** The heart failure referral and the consultation by Noelani Abernathy-Chen, MD (a fictional consultant), on the day of the two-week visit, are **S**. The consultant answers the six referral questions in line with what the record shows afterwards: HFrEF from ischemic cardiomyopathy; angiography within two weeks; all four classes started within weeks in the stated order and titrated with laboratory checks; intravenous iron twice; a repeat echocardiogram after 90 days of therapy before any ICD decision, and no CRT with a QRS of 104 ms; and cardiac rehabilitation, then a graded return to the ocean.
